RZLT

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Rezolute Inc

NASDAQ | RZLT

10.41

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 20, 2025)

$942.11M

Market Cap

-

P/E Ratio

-0.94

EPS

$11.46

52 Week High

$2.21

52 Week Low

HEALTHCARE

Sector

RZLT Chart

Recent Chart
Price Action

RZLT Technicals

Tags:

RZLT Earnings

Yearly Income Statement (As of Jun 30, 2025)

Field Value (USD)
Gross Profit -$31K
Total Revenue $0
Cost Of Revenue $31K
Costof Goods And Services Sold $31K
Operating Income -$80M
Selling General And Administrative $18M
Research And Development $62M
Operating Expenses $80M
Investment Income Net -
Net Interest Income $5.5M
Interest Income $5.5M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $31K
Income Before Tax -$74M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$74M
Comprehensive Income Net Of Tax -
Ebit -$80M
Ebitda -$80M
Net Income -$74M

Revenue & Profitability

Earnings Performance

RZLT Financials

yearly Balance Sheet (As of Jun 30, 2025)

Field Value (USD)
Total Assets $175M
Total Current Assets $171M
Cash And Cash Equivalents At Carrying Value $94M
Cash And Short Term Investments $94M
Inventory -
Current Net Receivables $700K
Total Non Current Assets $4.3M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $0
Short Term Investments $74M
Other Current Assets $3.3M
Other Non Current Assets -
Total Liabilities $13M
Total Current Liabilities $12M
Current Accounts Payable $5.8M
Deferred Revenue -
Current Debt -
Short Term Debt $632K
Total Non Current Liabilities $1.5M
Capital Lease Obligations $1.6M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $1.6M
Other Current Liabilities $5.5M
Other Non Current Liabilities -
Total Shareholder Equity $162M
Treasury Stock -
Retained Earnings -$404M
Common Stock $87K
Common Stock Shares Outstanding $76M

yearly Cash Flow (As of Jun 30, 2025)

Field Value (USD)
Operating Cashflow -$69M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $31K
Capital Expenditures $0
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$15M
Cashflow From Financing $107M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$74M

yearly Income Statement (As of Jun 30, 2025)

Field Value (USD)
Gross Profit -$31K
Total Revenue $0
Cost Of Revenue $31K
Costof Goods And Services Sold $31K
Operating Income -$80M
Selling General And Administrative $18M
Research And Development $62M
Operating Expenses $80M
Investment Income Net -
Net Interest Income $5.5M
Interest Income $5.5M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $31K
Income Before Tax -$74M
Income Tax Expense -
Interest And Debt Expense -
Net Income From Continuing Operations -$74M
Comprehensive Income Net Of Tax -
Ebit -$80M
Ebitda -$80M
Net Income -$74M

RZLT News

RZLT Profile

Rezolute Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Rezolute, Inc. is a clinical-stage biopharmaceutical company headquartered in Redwood City, California, dedicated to developing innovative therapies for rare and metabolic diseases. The company boasts a promising pipeline targeting significant unmet medical needs, underpinned by its commitment to scientific advancement and clinical excellence. Through strategic collaborations and a focus on improving patient outcomes, Rezolute is uniquely positioned to make a substantial impact in the biopharmaceutical sector, aiming to transform the treatment landscape for underserved patient populations.

LPTX
+368.57%
$2.05
AZI
+11.98%
$0.08
SOND
+115.30%
$0.19
IVP
+29.03%
$0.13
BNKK
+40.74%
$0.20
VHAI
+100.00%
$0.00
CHR
+20.54%
$0.05
ONDS
-4.33%
$7.50
BURU
+3.28%
$0.21
DNN
+2.10%
$2.43
NVDA
+3.91%
$193.82
TSLA
+0.68%
$403.99
AXDX
-61.36%
$0.03
INTC
+2.27%
$35.11
ACHR
-1.83%
$7.47
BITF
-5.45%
$2.60
PFE
-2.23%
$24.88
TLRY
-6.60%
$0.96
BYND
-2.43%
$0.97
VIVK
+4.44%
$0.13
EOSE
-5.19%
$12.78
PCG
-2.66%
$15.72
MARA
-6.56%
$11.10
ADAP
-15.14%
$0.05
WTO
+1.72%
$0.02
NIO
-3.84%
$5.75
WULF
+1.91%
$12.23
AUID
+34.25%
$2.17
IREN
-6.18%
$45.83
MNDR
+56.03%
$2.59
RGTI
-0.97%
$25.46
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
SNAP
-2.66%
$8.03
QBTS
+2.22%
$23.44
MU
-1.12%
$225.92
SRM
+53.27%
$10.30
BTBT
-9.24%
$2.16
T
-1.28%
$25.27
CYPH
-1.01%
$2.94
QUBT
-6.32%
$11.56
NFLX
-3.58%
$110.00
OWL
-0.86%
$13.79
KVUE
-1.04%
$16.06
ASBP
-6.14%
$0.09
STEC
+38.81%
$1.05
PLTD
+1.26%
$7.21
BBD
-1.66%
$3.54
BMNU
-18.00%
$6.92
CRCL
-8.98%
$69.72
WLGS
-5.57%
$0.04
SGBX
+36.07%
$8.26
BAC
+0.73%
$52.02
MTSR
-0.35%
$70.50
APLD
+1.09%
$23.09
CLSK
-5.45%
$10.22
EXAS
+17.78%
$101.50
SOUN
+0.86%
$11.63
META
-1.23%
$590.32
TWOH
-14.28%
$0.00
GPUS
-6.03%
$0.22
AFMD
-34.94%
$0.18
SMR
-1.90%
$21.13
VSA
+3.00%
$0.17
CLF
+0.62%
$11.26
CGC
-1.86%
$1.05
VZ
-0.69%
$41.19
ORCL
+2.28%
$225.53
RIOT
-4.23%
$13.35
BULL
-2.02%
$8.22
HIMS
-1.18%
$35.83
MP
+8.61%
$63.55
FCX
+3.12%
$41.25
GRYP
-10.38%
$1.38
TGT
-2.76%
$86.08
OLMA
-3.52%
$19.43
MODV
-25.22%
$0.43
CIFR
+13.95%
$16.65
GOOGL
+3.55%
$303.23
LEN
-0.69%
$115.16
APLT
-4.49%
$0.28
XOM
-1.41%
$117.35
OKLO
+6.44%
$102.86
AGNC
-0.29%
$10.08
KMI
-0.99%
$26.82
BMY
-2.69%
$45.79
KEY
+0.93%
$17.35
SAND
-6.04%
$12.12
AMC
-2.29%
$2.13
PLUG
+4.73%
$1.98
TMC
-1.29%
$5.35
BFLY
+19.40%
$2.40
SOFI
+4.92%
$28.03
SHOT
-74.37%
$0.39
PBR
-0.83%
$13.02
MRVL
+3.35%
$81.32
ZAPP
-46.30%
$0.15
ETHE
-5.77%
$24.16
DFLI
-8.92%
$0.70
LPTX
+368.57%
$2.05
AZI
+11.98%
$0.08
SOND
+115.30%
$0.19
IVP
+29.03%
$0.13
BNKK
+40.74%
$0.20
VHAI
+100.00%
$0.00
CHR
+20.54%
$0.05
ONDS
-4.33%
$7.50
BURU
+3.28%
$0.21
DNN
+2.10%
$2.43
NVDA
+3.91%
$193.82
TSLA
+0.68%
$403.99
AXDX
-61.36%
$0.03
INTC
+2.27%
$35.11
ACHR
-1.83%
$7.47
BITF
-5.45%
$2.60
PFE
-2.23%
$24.88
TLRY
-6.60%
$0.96
BYND
-2.43%
$0.97
VIVK
+4.44%
$0.13
EOSE
-5.19%
$12.78
PCG
-2.66%
$15.72
MARA
-6.56%
$11.10
ADAP
-15.14%
$0.05
WTO
+1.72%
$0.02
NIO
-3.84%
$5.75
WULF
+1.91%
$12.23
AUID
+34.25%
$2.17
IREN
-6.18%
$45.83
MNDR
+56.03%
$2.59
RGTI
-0.97%
$25.46
RMBL
+60.50%
$3.21
LNW
-3.71%
$86.22
ADD
-25.47%
$0.05
SNAP
-2.66%
$8.03
QBTS
+2.22%
$23.44
MU
-1.12%
$225.92
SRM
+53.27%
$10.30
BTBT
-9.24%
$2.16
T
-1.28%
$25.27
CYPH
-1.01%
$2.94
QUBT
-6.32%
$11.56
NFLX
-3.58%
$110.00
OWL
-0.86%
$13.79
KVUE
-1.04%
$16.06
ASBP
-6.14%
$0.09
STEC
+38.81%
$1.05
PLTD
+1.26%
$7.21
BBD
-1.66%
$3.54
BMNU
-18.00%
$6.92
CRCL
-8.98%
$69.72
WLGS
-5.57%
$0.04
SGBX
+36.07%
$8.26
BAC
+0.73%
$52.02
MTSR
-0.35%
$70.50
APLD
+1.09%
$23.09
CLSK
-5.45%
$10.22
EXAS
+17.78%
$101.50
SOUN
+0.86%
$11.63
META
-1.23%
$590.32
TWOH
-14.28%
$0.00
GPUS
-6.03%
$0.22
AFMD
-34.94%
$0.18
SMR
-1.90%
$21.13
VSA
+3.00%
$0.17
CLF
+0.62%
$11.26
CGC
-1.86%
$1.05
VZ
-0.69%
$41.19
ORCL
+2.28%
$225.53
RIOT
-4.23%
$13.35
BULL
-2.02%
$8.22
HIMS
-1.18%
$35.83
MP
+8.61%
$63.55
FCX
+3.12%
$41.25
GRYP
-10.38%
$1.38
TGT
-2.76%
$86.08
OLMA
-3.52%
$19.43
MODV
-25.22%
$0.43
CIFR
+13.95%
$16.65
GOOGL
+3.55%
$303.23
LEN
-0.69%
$115.16
APLT
-4.49%
$0.28
XOM
-1.41%
$117.35
OKLO
+6.44%
$102.86
AGNC
-0.29%
$10.08
KMI
-0.99%
$26.82
BMY
-2.69%
$45.79
KEY
+0.93%
$17.35
SAND
-6.04%
$12.12
AMC
-2.29%
$2.13
PLUG
+4.73%
$1.98
TMC
-1.29%
$5.35
BFLY
+19.40%
$2.40
SOFI
+4.92%
$28.03
SHOT
-74.37%
$0.39
PBR
-0.83%
$13.02
MRVL
+3.35%
$81.32
ZAPP
-46.30%
$0.15
ETHE
-5.77%
$24.16
DFLI
-8.92%
$0.70
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.